Study to Assess on a Molecular Level the Influence of a 5 % Dexpanthenol Ointment in Subjects With Superficial Injuries
Phase 4
Completed
- Conditions
- Gene ExpressionCell ProliferationWound Healing
- Interventions
- Drug: PlaceboDrug: Dexpanthenol (BAY81-2996)
- Registration Number
- NCT00859196
- Lead Sponsor
- Bayer
- Brief Summary
In previous in vitro studies it could be shown, that Dexpanthenol has an influence on the gene expression of fibroblasts. The genes which are influenced by Dexpanthenol play mainly a role during cell proliferating processes.The aim of this study is to investigate the molecular effect of Dexpanthenol on human living skin, during wound healing.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 15
Inclusion Criteria
- Skin type I to IV
- Willingness to avoid intensive sunlight exposure two weeks before the start of the study and at least 2 months after removal of the stitches
Read More
Exclusion Criteria
- Active skin disease, moles, tattoos, strong pigmentation at the test area or scars in the test area that would influence the visual scoring
- History of keloids and hypertrophic scars
- Frequent visits of tanning booths
- Intake of drugs interfering with the immune system (e.g. antiphlogistics, corticosteroids, immunosuppressants, and antihistamines) within 30 days before day 1 as well as during the study.
Read More
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Arm 2 Placebo - Arm 1 Dexpanthenol (BAY81-2996) -
- Primary Outcome Measures
Name Time Method Investigation of gene expression in dermal fibroblasts and keratinocytes on a molecular level. Analysis of skin biopsies taken 24h, 72h and 144h after wounding
- Secondary Outcome Measures
Name Time Method